Aspartame, low-calorie sweeteners and disease: Regulatory safety and epidemiological issues

Food and Chemical Toxicology

Volumn 60, Issue , 2013, Pages 109-115

  Marinovich, Marina ^a   Galli, Corrado L ^a   Bosetti, Cristina ^b   Gallus, Silvano ^b   La Vecchia, Carlo ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Aspartame; Cancer risk; Sweeteners; Toxicity

Indexed keywords

ASPARTAME; SWEETENING AGENT;

BRAIN CANCER; BRAIN TUMOR; BREAST CANCER; CANCER RISK; CARCINOGENICITY; CASE CONTROL STUDY; DENMARK; DIETARY INTAKE; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; FOOD SAFETY; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; ITALY; KIDNEY CANCER; LEUKEMIA; MULTIPLE MYELOMA; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PREMATURE LABOR; PROSTATE CANCER; REVIEW; UNITED STATES; VASCULAR DISEASE;

ASPARTAME; CANCER RISK; SWEETENERS; TOXICITY;

ASPARTAME; CARDIOVASCULAR DISEASES; ENERGY INTAKE; FEMALE; HUMANS; MALE; NEOPLASMS; OBSERVATIONAL STUDY AS TOPIC; RISK ASSESSMENT; SWEETENING AGENTS;

EID: 84882285934     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.07.040     Document Type: Review

References (72)

1. Andreatta M.M., Muñoz S.E., Lantieri M.J., Eynard A.R., Navarro A. Artificial sweetener consumption and urinary tract tumors in Cordoba. Argentina. Prev. Med. 2008, 47:136-139.
2. Bao Y., Stolzenberg-Solomon R., Jiao L., Silverman D.T., Subar A.F., Park Y., Leitzmann M.F., Hollenbeck A., Schatzkin A., Michaud D.S. Added sugar and sugar-sweetened foods and beverages and the risk of pancreatic cancer in the National Institutes of Health-AARP Diet and Health Study. Am. J. Clin. Nutr. 2008, 88:431-440.
3. Bosetti C., Gallus S., Talamini R., Montella M., Franceschi S., Negri E., La Vecchia C. Artificial sweeteners and the risk of gastric, pancreatic, and endometrial cancers in Italy. Cancer Epidemiol. Biomarkers Prev. 2009, 18:2235-2238.
4. Bravo M.P., Del Rey-Calero J., Conde M. Risk factors of bladder cancer in Spain. Neoplasma 1987, 34:633-637.
5. Bunin G.R., Kushi L.H., Gallagher P.R., Rorke-Adams L.B., McBride M.L., Cnaan A. Maternal diet during pregnancy and its association with medulloblastoma in children: a children's oncology group study (United States). Cancer Causes Control 2005, 16:877-891.
6. Butchko H.H. Safety of aspartame. Lancet 1997, 349:1105.
7. Butchko H.H., Stargel W.W. Aspartame: scientific evaluation in the postmarketing period. Regul. Toxicol. Pharmacol. 2001, 34:221-233.
8. Butchko H.H., Stargel W.W., Comer C.P., Mayhew D.A., Benninger C., Blackburn G.L., de Sonneville L.M., Geha R.S., Hertelendy Z., Koestner A., Leon A.S., Liepa G.U., McMartin K.E., Mendenhall C.L., Munro I.C., Novotny E.J., Renwick A.G., Schiffman S.S., Schomer D.L., Shaywitz B.A., Spiers P.A., Tephly T.R., Thomas J.A., Trefz F.K. Intake of aspartame versus the Acceptable Daily Intake. Regul. Toxicol. Pharmacol. 2002, 35:S13-S16.
9. Butchko H.H., Stargel W.W., Comer C.P., Mayhew D.A., Benninger C., Blackburn G.L., de Sonneville L.M., Geha R.S., Hertelendy Z., Koestner A., Leon A.S., Liepa G.U., McMartin K.E., Mendenhall C.L., Munro I.C., Novotny E.J., Renwick A.G., Schiffman S.S., Schomer D.L., Shaywitz B.A., Spiers P.A., Tephly T.R., Thomas J.A., Trefz F.K. Aspartame: review of safety. Regul. Toxicol. Pharmacol. 2002, 35:S1-S93.
10. Caldwell J.C., Jinot J., DeVoney D., Gift J.S. Evaluation of evidence for infection as a mode of action for induction of rat lymphoma. Environ. Mol. Mutagen. 2008, 49(2):155-164.
11. Capen, C.C., Dybing, E., Rice, J.M., Wilbourn, J.D., 1999. Species differences in thyroid, kidney and urinary bladder carcinogenesis. IARC Scientific Publ. No. 147. Lyon, France: International Agency for Research on Cancer.
12. Chan J.M., Wang F., Holly E.A. Sweets, sweetened beverages, and risk of pancreatic cancer in a large population-based case-control study. Cancer Causes Control 2009, 20:835-846.
13. Cohen S.M. Human relevance of animal carcinogenicity studies. Regul. Toxicol. Pharmacol. 1995, 21:75-80. discussion 81-76.
14. Dhingra R., Sullivan L., Jacques P.F., Wang T.J., Fox C.S., Meigs J.B., D'Agostino R.B., Gaziano J.M., Vasan R.S. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation 2007, 116:480-488.
15. EFSA Opinion of the Scientific Committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic. EFSA J. 2005, 282:1-31.
16. EFSA Opinion of the scientific panel AFC related to new long-term carcinogenicity study on aspartame. EFSA J. 2006, 356:1-44.
17. EFSA Guidance of the Scientific Committee on a request from EFSA on the use of the benchmark dose approach in risk assessment. EFSA J. 2009, 1150:1-72.
18. EFSA Statement on two recent scientific articles on the safety of artificial sweeteners. EFSA J. 2011, 9:1996.
19. EFSA EFSA Statement on the scientific evaluation of two studies related to the safety of artificial sweeteners. EFSA J. 2011, 9:2089.
20. EFSA Overview of the procedures currently used at EFSA for the assessment of dietary exposure to different chemical substances. EFSA J. 2011, 9(12):2490.
21. EFSA Guidance for submission for food additive evaluations. EFSA J. 2012, 10(7):60. 10.2903/j.efsa.2012.276.
22. EFSA, 2013. DRAFT Scientific Opinion on the re-evaluation of aspartame (E 951) as a food additive. http://www.efsa.europa.eu/it/consultationsclosed/call/130108.pdf.
23. Elcock M., Morgan R.W. Update on artificial sweeteners and bladder cancer. Regul. Toxicol. Pharmacol. 1993, 17:35-43.
24. Englund-Ögge L., Brantsæter A.L., Haugen M., Sengpiel V., Khatibi A., Myhre R., Myking S., Meltzer H.M., Kacerovsky M., Nilsen R.M., Jacobsson B. Association between intake of artificially sweetened and sugar-sweetened beverages and preterm delivery: a large prospective cohort study. Am. J. Clin. Nutr. 2012, 96:552-559.
25. Ewertz M., Gill C. Dietary factors and breast-cancer risk in Denmark. Int. J. Cancer. 1990, 46:779-784.
26. FDA Food additives permitted for direct addition to food for human consumption: aspartame. Food and Drug Administration. Federal Register 1984, 49:6672.
27. FDA, 2000. Toxicological principles for the safety assessment of food ingredients: FDA Redbook 2000: Section IV.C.6. Carcinogenicity studies with rodents. January 2006, p. 21. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/.
28. FDA, 2007. FDA Statement on European Aspartame Study. (accessed 12.01.08). http://www.cfsan.fda.gov/~lrd/fpaspar2.html.
29. Fry J. The world market for intense sweeteners. World Rev. Nutr. Diet. 1999, 85:201-211.
30. Fung T.T., Malik V., Rexrode K.M., Manson J.E., Willett W.C., Hu F.B. Sweetened beverage consumption and risk of coronary heart disease in women. Am. J. Clin. Nutr. 2009, 89:1037-1042.
31. Gallus S., Scotti L., Negri E., Talamini R., Franceschi S., Montella M., Giacosa A., Dal Maso L., La Vecchia C. Artificial sweeteners and cancer risk in a network of case-control studies. Ann. Oncol. 2007, 18:40-44.
32. Gardener H., Rundek T., Markert M., Wright C.B., Elkind M.S., Sacco R.L. Diet soft drink consumption is associated with an increased risk of vascular events in the Northern Manhattan study. J. Gen. Intern. Med. 2012, 27:1120-1126.
33. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol. Rev. 1987, 9:1-30.
34. Gurney J.G., Pogoda J.M., Holly E.A., Hecht S.S., Preston-Martin S. Aspartame consumption in relation to childhood brain tumor risk: results from a case-control study. J. Natl. Cancer Inst. 1997, 89:1072-1074.
35. Halldorsson T. Intake of artificially sweetened soft drinks and risk of preterm delivery. Am. J. Clin. Nutr. 2010, 92. (author reply 1540-1542).
36. Halldorsson T.I., Strom M., Petersen S.B., Olsen S.F. Intake of artificially sweetened soft drinks and risk of preterm delivery: a prospective cohort study in 59,334 Danish pregnant women. Am. J. Clin. Nutr. 2010, 92:626-633.
37. Hayes A.W., Dayan A.D., Hall W.C., Kodell R.L., Williams G.M., Waddell W.D. A review of mammalian carcinogenicity study design and potential effects of alternate procedures on the safety evaluation of food ingredients. Regulatory Toxicol. Pharmacol. 2011, 59:142-175.
38. Hoover R.N., Strasser P.H. Artificial sweeteners and human bladder cancer. Preliminary results. Lancet 1980, 1:837-840.
39. Howe G.R., Burch J.D., Miller A.B., Morrison B., Gordon P., Weldon L., Chambers L.W., Fodor G., Winsor G.M. Artificial sweeteners and human bladder cancer. Lancet 1977, 2:578-581.
40. ICH (International Conference for Harmonization), 1997. Testing for carcinogenicity of pharmaceuticals. Guideline S1B. US Fed. Reg. 63: 8983; EU: CPMP/ICH/299/95.
41. JECFA, 1980. Aspartame; Evaluation of certain food additives. Joint FAO/WHO Expert Committee on Food Additives. Technical Report Series 653. World Health Organization, Geneva.
42. Jeffrey A.M., Williams G.M. Lack of DNA-damaging activity of five non-nutritive sweeteners in the rat hepatocyte/DNA repair assay. Food Chem. Toxicol. 2000, 38:335-338.
43. La Vecchia C. Intake of artificially sweetened soft drinks and risk of preterm delivery. Am. J. Clin. Nutr. 2010, 92:1540.
44. La Vecchia C. Low-calorie sweeteners and the risk of preterm delivery: results from two studies and a meta-analysis. J. Fam. Plan. Reprod. Health Care 2013, 39:12-13.
45. Lim U., Subar A.F., Mouw T., Hartge P., Morton L.M., Stolzenberg-Solomon R., Campbell D., Hollenbeck A.R., Schatzkin A., et al. Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1654-1659.
46. Magnuson B., Williams G.M. Carcinogenicity of aspartame in rats not proven. Environ. Health Perspect. 2008, 116(6):A239-A240.
47. Magnuson B.A., Burdock G.A., Doull J., Kroes R.M., Marsh G.M., Pariza M.W., Spencer P.S., Waddell W.J., Walker R., Williams G.M. Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Crit. Rev. Toxicol. 2007, 37:629-727.
48. NTP (US National Toxicology Program), 2005. NTP report on the toxicology studies of aspartame (CAS No. 22839-47-0) in genetically modified (FVB Tg.AC hemizygous) and B6.129-Cdkn2atm1Rdp (N2) deficient mice and carcinogenicity studies of aspartame in genetically modified [B6.129-Trp53tm1Brd (N5) haploinsufficient] mice (feed studies). National Toxicology Program Genetically Modified Model, Report. Oct, pp. 1-222.
49. OECD (Organization for Economic Cooperation and Development), 1981. OECDGuideline for Testing of Chemicals. Guideline 451: Carcinogenicity Studies, Adopted May 12, 1991.
50. OECD, 2009a. OECD Guideline for the Testing of Chemicals. Test Guideline 451: Carcinogenicity Studies. http://lysander.sourceoecd.org/vl=1999285/cl=28/nw=1/rpsv/cw/vhosts/oecdjournals/1607310x/v1n4/contp1-1.htm.
51. OECD, 2009b. Draft Guidance Document on the Design and Conduct of Chronic Toxicity and Carcinogenicity Studies, Series on Testing and Assessment No. 116. http://www.oecd.org/document/55/0,3343,en_2649_34377_2349687_1_1_1_1,00.html.
52. Olney J.W., Farber N.B., Spitznagel E., Robins L.N. Increasing brain tumor rates: is there a link to aspartame?. J. Neuropathol. Exp. Neurol. 1996, 55:1115-1123.
53. Ranney R.E., Mares S.E., Schroeder R.E., Hutsell T.C., Radzialowski F.M. The phenylalanine and tyrosine content of maternal and fetal body fluids from rabbits fed aspartame. Toxicol. Appl. Pharmacol. 1975, 32:339-346.
54. Rencüzoǧullari E., Tüylü B.A., Topaktaş M., Ila H.B., Kayraldiz A., Arslan M., Diler S.B. Genotoxicity of aspartame. Drug Chem. Toxicol. 2004, 27(3):257-268.
55. Roe F.J. A brief history of the use of laboratory animals for the prediction of carcinogenic risk for man with a note on needs for the future. Exp. Toxicol. Pathol. 1998, 50(4-6):271-276.
56. Ross J.A. Brain tumors and artificial sweeteners? A lesson on not getting soured on epidemiology. Med. Pediatr. Oncol. 1998, 30:7-8.
57. Sasaki Y.F., Kawaguchi S., Kamaya A., Ohshita M., Kabasawa K., Iwama K., Taniguchi K., Tsuda S. The comet assay with 8 mouse organs: results with 39 currently used food additives. Mutat. Res. 2002, 519:103-119.
58. SCF (Scientific Committee on Food), 1985. Sweeteners. Reports of the Scientific Committee for Food (Sixteenth Series), EUR 10210 EN, Commission of the European Communities, Luxembourg.
59. SCF (Scientific Committee on Food), 1989. Sweeteners. Reports of the Scientific Committee for Food (Twenty-first Series), EUR 11617 EN, Commission of the European Communities, Luxembourg.
60. SCF (Scientific Committee on Food), 1997. Minutes of the 107th Meeting of the Scientific Committee for Food, held on 12-13 June 1997 in Brussels. http://europa.eu.int/comm/food/fs/sc/oldcomm7/out13_en.html.
61. SCF (Scientific Committee on Food), 2002. Opinion of the Scientific Committee on Food: Update on the Safety of Aspartame (expressed on 4 December 2002). http://ec.europa.eu/food/fs/sc/scf/out155_en.pdf.
62. Schernhammer E.S., Bertrand K.A., Birmann B.M., Sampson L., Willett W.C., Feskanich D. Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women. Am. J. Clin. Nutr. 2012, 96:1419-1428.
63. Schoeb T.R., McConnell E.E. Commentary. Further comments on mycoplasma pulmonis and lymphoma in bioassays of rats. Vet. Pathol. 2011, 48:420-426.
64. Schoeb T.R., McConnell E.E., Juliana M.M., Davis J.K., Davidson M.K., Lindsey J.R. Mycoplasma pulmonis and lymphoma in bioassays in rats. Vet. Pathol. 2009, 46:952-959.
65. Soffritti M., Belpoggi F., Degli Esposti D., Lambertini L., Tibaldi E., Rigano A. First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats. Environ. Health Perspect. 2006, 114:379-385.
66. Soffritti M., Belpoggi F., Tibaldi E., Esposti D.D., Lauriola M. Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats. Environ. Health Perspect. 2007, 115:1293-1297.
67. Soffritti M., Belpoggi F., Manservigi M., Tibaldi E., Lauriola M., Falcioni L., Bua L. Aspartame administered in feed, beginning prenatally through life span, induces cancers of the liver and lung in male Swiss mice. Am. J. Ind. Med. 2010, 53:1197-1206.
68. Stegink L.D., Filer L.J., Bell E.F., Ziegler E.E., Tephly T.R., Krause W.L. Repeated ingestion of aspartame-sweetened beverages: further observations in individuals heterozygous for phenylketonuria. Metabolism 1990, 39(10):1076-1081.
69. Stegink L.D., Lindgren S.D., Brummel M.C., Stumbo P.J., Wolraich M.L. Erythrocyte L-aspartyl-L-phenylalanine hydrolase activity and plasma phenylalanine and aspartate concentrations in children consuming diets high in aspartame. Am. J. Clin. Nutr. 1995, 62(6):1206-1211.
70. Sturgeon S.R., Hartge P., Silverman D.T., Kantor A.F., Linehan W.M., Lynch C., Hoover R.N. Associations between bladder cancer risk factors and tumor stage and grade at diagnosis. Epidemiology 1994, 5:218-225.
71. Walker A.M., Dreyer N.A., Friedlander E., Loughlin J., Rothman K.J., Kohn H.I. An independent analysis of the National Cancer Institute study on non-nutritive sweeteners and bladder cancer. Am. J. Public. Health 1982, 72:376-381.
72. Weihrauch M.R., Diehl V. Artificial sweeteners-do they bear a carcinogenic risk?. Ann. Oncol. 2004, 15:1460-1465.